Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features
出版年份 2019 全文链接
标题
Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features
作者
关键词
-
出版物
Cancers
Volume 11, Issue 12, Pages 1844
出版商
MDPI AG
发表日期
2019-11-22
DOI
10.3390/cancers11121844
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genetic abnormalities and pathophysiology of MDS
- (2019) Naoko Hosono International Journal of Clinical Oncology
- U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies
- (2019) Molly A. Smith et al. NATURE CELL BIOLOGY
- Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation
- (2019) Jia Yi Fong et al. CANCER CELL
- Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes
- (2019) Vikas Madan et al. AMERICAN JOURNAL OF HEMATOLOGY
- The evolving role of next generation sequencing in myelodysplastic syndromes
- (2019) Travis P. Spaulding et al. BRITISH JOURNAL OF HAEMATOLOGY
- Spliceosomal disruption of the non-canonical BAF complex in cancer
- (2019) Daichi Inoue et al. NATURE
- Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged ≥ 75 years
- (2018) Victoria V. Prassek et al. HAEMATOLOGICA
- Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis
- (2018) Pourya Arbab Jafari et al. Hematology
- SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells
- (2018) Yang Liang et al. LEUKEMIA
- H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
- (2018) Michael Seiler et al. NATURE MEDICINE
- Prp8 positioning of U5 snRNA is linked to 5′ splice site recognition
- (2018) Andrew J. MacRae et al. RNA
- Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
- (2018) Hsin-An Hou et al. Blood Cancer Journal
- Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged ≥ 75 years
- (2018) Victoria V. Prassek et al. HAEMATOLOGICA
- Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
- (2018) Yusuke Shiozawa et al. Nature Communications
- Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1
- (2018) Dennis Liang Fei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or TET2 Mutation?
- (2018) JINMING SONG et al. Cancer Genomics & Proteomics
- Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure
- (2018) Lena Dorsheimer et al. JAMA Cardiology
- The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes
- (2017) Bon Ham Yip et al. JOURNAL OF CLINICAL INVESTIGATION
- Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study
- (2017) Uwe Platzbecker et al. LANCET ONCOLOGY
- Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
- (2017) Ting Han et al. SCIENCE
- Prognostic value of SRSF2 mutations in patients with de novo myelodysplastic syndromes: A meta-analysis
- (2017) Xue Zheng et al. PLoS One
- Physiologic Expression of Sf3b1 K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation
- (2016) Esther A. Obeng et al. CANCER CELL
- SF3B1/Hsh155 HEAT motif mutations affect interaction with the spliceosomal ATPase Prp5, resulting in altered branch site selectivity in pre-mRNA splicing
- (2016) Qing Tang et al. GENES & DEVELOPMENT
- A randomized phase II trial of azacitidine +/- epoetin- in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents
- (2016) S. Thepot et al. HAEMATOLOGICA
- Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes
- (2016) H Dolatshad et al. LEUKEMIA
- U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3′ End Formation
- (2016) Sung Mi Park et al. MOLECULAR CELL
- Therapeutic targeting of splicing in cancer
- (2016) Stanley Chun-Wei Lee et al. NATURE MEDICINE
- Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
- (2016) Hsin-An Hou et al. Oncotarget
- A randomized phase II trial of azacitidine +/- epoetin- in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents
- (2016) S. Thepot et al. HAEMATOLOGICA
- SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
- (2015) Eunhee Kim et al. CANCER CELL
- Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
- (2015) Cara Lunn Shirai et al. CANCER CELL
- Charting the “Splice” Routes to MDS
- (2015) Esther A. Obeng et al. CANCER CELL
- SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment
- (2015) Syed A. Mian et al. Nature Communications
- Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
- (2015) Vikas Madan et al. Nature Communications
- Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
- (2015) Rachel B. Darman et al. Cell Reports
- Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3’ Splice Site Selection in SF3B1-mutated Cancers
- (2015) Christopher DeBoever et al. PLoS Computational Biology
- SF3B1mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
- (2014) Chien-Chin Lin et al. AMERICAN JOURNAL OF HEMATOLOGY
- Splicing factor mutations in AML
- (2014) S. Ogawa BLOOD
- Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
- (2014) H Dolatshad et al. LEUKEMIA
- PRPF8 defects cause missplicing in myeloid malignancies
- (2014) A Kurtovic-Kozaric et al. LEUKEMIA
- Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms
- (2013) B. Przychodzen et al. BLOOD
- In vivo mutation of pre-mRNA processing factor 8 (Prpf8) affects transcript splicing, cell survival and myeloid differentiation
- (2013) Maria-Cristina Keightley et al. FEBS LETTERS
- The Changing Mutational Landscape of Acute Myeloid Leukemia and Myelodysplastic Syndrome
- (2013) Connie A. Larsson et al. MOLECULAR CANCER RESEARCH
- Defects in spliceosomal machinery: a new pathway of leukaemogenesis
- (2012) Jaroslaw P. Maciejewski et al. BRITISH JOURNAL OF HAEMATOLOGY
- The development and application of small molecule modulators of SF3b as therapeutic agents for cancer
- (2012) Thomas R. Webb et al. DRUG DISCOVERY TODAY
- Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders
- (2012) V Visconte et al. LEUKEMIA
- The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts
- (2012) M Nikpour et al. LEUKEMIA
- The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region
- (2011) E. G. Folco et al. GENES & DEVELOPMENT
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
- (2011) E. Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Spliceosome: Design Principles of a Dynamic RNP Machine
- (2009) Markus C. Wahl et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started